Please use this identifier to cite or link to this item:
|Title:||Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase.||Austin Authors:||Phillips, P A;Sasadeus, J;Hodsman, G P;Horowitz, J D;Saltups, A;Johnston, Colin I||Affiliation:||Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia||Issue Date:||1-Feb-1989||Publication information:||British Heart Journal; 61(2): 139-43||Abstract:||Plasma concentrations of immunoreactive atrial natriuretic peptide (mean (SEM] were measured in 135 patients admitted to two coronary care units with myocardial infarction, ischaemic chest pain, or non-ischaemic chest pain. Concentrations were significantly higher in patients with acute myocardial infarction not treated with systemic thrombolysis (60.4 (14.3) pg/ml) than in patients with non-ischaemic chest pain (21.1 (4.3) pg/ml). Patients with ischaemic chest pain had intermediate values (39.3 (7.1) pg/ml). Patients with acute myocardial infarction treated with intravenous streptokinase had normal concentrations of plasma atrial natriuretic peptide (20.2 (3.6) pg/mg), which were significantly lower than those in patients with myocardial infarction not given streptokinase. These changes could not be explained by factors such as age, pre-existing hypertension, renal dysfunction, or cardiac failure, nor treatment other than streptokinase. Raised plasma concentrations of atrial natriuretic peptide in acute myocardial infarction may be a homoeostatic response acting to reduce atrial pressures by natriuresis, diuresis, and venodilatation. The lower concentrations of atrial natriuretic peptide in patients with acute myocardial infarction treated with streptokinase may reflect a short term beneficial haemodynamic effect of streptokinase.||Gov't Doc #:||2522310||URI:||http://ahro.austin.org.au/austinjspui/handle/1/12392||URL:||https://pubmed.ncbi.nlm.nih.gov/2522310||Type:||Journal Article||Subjects:||Angina Pectoris.blood
Atrial Natriuretic Factor.blood
Myocardial Infarction.blood.drug therapy
|Appears in Collections:||Journal articles|
Show full item record
checked on Nov 28, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.